Selpercatinib in Patients With RET Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial

por Drilon, Alexander, Subbiah, Vivek, Gautschi, Oliver, Tomasini, Pascale, de Braud, Filippo, Solomon, Benjamin J., Shao-Weng Tan, Daniel, Alonso, Guzmán, Wolf, Jürgen, Park, Keunchil, Goto, Koichi, Soldatenkova, Victoria, Szymczak, Sylwia, Barker, Scott S., Puri, Tarun, Bence Lin, Aimee, Loong, Herbert, Besse, Benjamin
Publicado 2023